SPRINTER® LEGEND SPL30015XRecalls & reported problems
Medtronic, Inc. · BLN SPL30015X SPR LEG 3.0X15 RX US M · Class 2
All models of SPRINTER LEGEND (19)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00613994901583), received between Mar 6, 2018 and Mar 6, 2018 — classified as 1 injury.
The most frequently reported specific device problem is “Burst Container or Vessel” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Burst Container or Vessel1
- Detachment of Device or Device Component1
Patient problems
- Device Embedded In Tissue or Plaque1
- Embolism1
- Patient Problem/Medical Problem1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryMar 6, 2018Burst Container or Vessel; Detachment of Device or Device Component; Burst Container or Vessel; Detachment of Device or Device Component
A SPRINTER LEGEND RX BALLOON CATHETER WAS INTENDED TO BE USED TO TREAT A SEVERELY CALCIFIED AND MODERATELY TORTUOUS PROXIMAL RCA LESION. THERE WERE NO ABNORMALITIES REPORTED IN RELATION TO THE ANATOMY. THERE WAS NO DAMAGE NOTED TO PACKAGING. THERE WERE NO ISSUES WHEN REMOVING THE DEVICE FROM THE HOOP. THE DEVICE WAS INSPECTED WITH NO ISSUES. NEGATIVE PREP WAS PERFORMED WITH NO ISSUES NOTED. IT WAS REPORTED THAT A BALLOON BURST OCCURRED DURING BALLOON INFLATION TO 21ATM. THE ISSUE OCCURRED ON THE FIRST INFLATION AND THERE WAS A SUDDEN DROP IN PRESSURE. THE DEVICE HAD NOT BEEN MOVED/RE-POSITIONED IN THE LESION PRIOR TO THE BURST. IT WAS REPORTED THAT THERE WAS A BALLOON FRAGMENT THAT WAS UNABLE TO BE REMOVED FROM THE PATIENT. A RESOLUTE ONYX DRUG ELUTING STENT WAS USED TO TRAP THE BALLOON FRAGMENT. IT WAS ALSO REPORTED THAT A MARKER BAND WAS VISUALIZED IN THE ARTERY AFTER THE BALLOON BURST. THE PHYSICIAN BELIEVES THAT THE MARKER BAND VISUALISED IN THE SMALL DISTAL BRANCH OF THE RCA IS FROM THE BURST SPRINTER LEGEND BALLOON. THE PHYSICIAN COMPLETED THE PROCEDURE. NO PATIENT INJURY REPORTED AND THE PATIENT IS REPORTED TO BE DOING FINE.
Patient problems: Device Embedded In Tissue or Plaque; Embolism; Patient Problem/Medical Problem
MAUDE report 7316664 ↗
Other Catheters, transluminal coronary angioplasty, percutaneous devices
- MINI TREK™ 1012270-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous223 reports
- Maverick²™ H7493892815200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous1 death203 reports
- MINI TREK™ 1012270-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous162 reports
- Maverick²™ H7493892820200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous161 reports
- NC TREK 1012454-08Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 recalls59 reports
- TREK™ 1012272-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 deaths158 reports
- NC TREK 1012453-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall84 reports
- NC TREK 1012453-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall1 death83 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page